CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | Kinney Gene G. President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −187,000 | 0 | ||
| 2021-02-12 | Kinney Gene G. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +140,601 | 140,601 | ||
| 2021-02-12 | Selkoe Dennis J. Director | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-02-12 | Selkoe Dennis J. Director | Grant or award · Employee Stock Option (Right to Buy) | +9,803 | 9,803 | ||
| 2021-02-12 | Selkoe Dennis J. Director | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-02-12 | Selkoe Dennis J. Director | Grant or award · Employee Stock Option (Right to Buy) | +8,426 | 8,426 | ||
| 2021-02-12 | Selkoe Dennis J. Director | Returned to the company · Employee Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2021-02-12 | Selkoe Dennis J. Director | Grant or award · Employee Stock Option (Right to Buy) | +6,315 | 6,315 | ||
| 2021-02-12 | HENNEY CHRISTOPHER S Director | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-02-12 | HENNEY CHRISTOPHER S Director | Grant or award · Employee Stock Option (Right to Buy) | +9,803 | 9,803 | ||
| 2021-02-12 | HENNEY CHRISTOPHER S Director | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-02-12 | HENNEY CHRISTOPHER S Director | Grant or award · Employee Stock Option (Right to Buy) | +8,426 | 8,426 | ||
| 2021-02-12 | HENNEY CHRISTOPHER S Director | Returned to the company · Employee Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2021-02-12 | HENNEY CHRISTOPHER S Director | Grant or award · Employee Stock Option (Right to Buy) | +6,315 | 6,315 | ||
| 2021-02-12 | Karp Carol D. Chief Regulatory Officer | Returned to the company · Employee Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2021-02-12 | Karp Carol D. Chief Regulatory Officer | Grant or award · Employee Stock Option (Right to Buy) | +51,282 | 51,282 | ||
| 2021-02-12 | Karp Carol D. Chief Regulatory Officer | Returned to the company · Employee Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2021-02-12 | Karp Carol D. Chief Regulatory Officer | Grant or award · Employee Stock Option (Right to Buy) | +45,112 | 45,112 | ||
| 2020-08-17 | Kinney Gene G. President and CEO | Option exercise | +10,000 | $6.41 | $64K | 12,793 |
| 2020-08-17 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −10,000 | 99,074 |
Page 39 of 41 · 819 trades